Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, bloating can occur with Wegovy (semaglutide). It is listed among the gastrointestinal effects associated with the medicine, and many people notice abdominal fullness, pressure or distension, particularly in the first few weeks of treatment or after a dose increase. That said, bloating on its own is rarely the full story — and the reason it happens is worth understanding properly. Wegovy is a prescription-only medicine; a prescriber assesses whether it is clinically suitable for you before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The most common thing people read online is that stomach side effects are a sign Wegovy isn't working or isn't right for them. That's not what the evidence shows. Semaglutide works partly by slowing how quickly food moves through your stomach, a mechanism called delayed gastric emptying. The result is that you feel fuller for longer, which is useful for weight management, but it also means gas and undigested food stay in the gut for longer than usual. Bloating is, in a literal sense, a by-product of the medicine doing its job. The NHS's information on semaglutide lists abdominal distension and flatulence alongside the more frequently mentioned nausea, and this reflects what came through consistently in the clinical trials. So if you're reading this because your jeans felt tight a few days after your first injection, that's an extremely familiar picture. Most people find it settles. The question is how to manage it while it does, and when to take it more seriously.
For a broader picture of what the clinical programme found, the full side-effect profile of the injection is covered in detail on our Wegovy side effects page.
The Wegovy titration schedule is deliberately gradual (doses step up roughly every four weeks) and there is a reason for that pacing. Your gut needs time to recalibrate to a slower transit rate. In the STEP 1 trial, published in the New England Journal of Medicine, gastrointestinal events were most common early in treatment and around each dose increase, with the majority being mild to moderate in severity. Bloating follows the same pattern: it tends to spike when the dose changes and then gradually fades as that dose becomes routine.
Practically, a few things can help. Eating more slowly, reducing portion sizes and cutting back on the obvious culprits (carbonated drinks, very fatty or very fibrous foods in large quantities) tends to reduce the volume of gas produced. This isn't a cure, but it makes the adjustment period more manageable. Some people also find that gas-related discomfort appears alongside burping; if that's part of your experience, there's specific information on our Wegovy and burping page and separately on gas as a side effect. Staying well hydrated helps too, since dehydration can worsen constipation and compound that bloated feeling.
This section matters most. Ordinary bloating from Wegovy is uncomfortable but not dangerous. There are, however, gastrointestinal symptoms associated with GLP-1 medicines that do require urgent attention, and it is important not to attribute everything to routine adjustment.
In January 2026, the MHRA issued a Drug Safety Update specifically highlighting acute pancreatitis as a known, infrequent but potentially serious effect of GLP-1 receptor agonists including semaglutide. The warning sign to act on is severe abdominal pain, the kind that does not ease, that is significantly worse than typical bloating discomfort, and that may radiate through to the back, with or without vomiting. If that describes what you are experiencing, stop taking the medicine and seek medical help promptly. Do not wait for a scheduled appointment.
Gallbladder problems are also associated with rapid weight loss and GLP-1 treatment. Pain in the upper right abdomen, particularly after eating fatty food, is the pattern to watch for. Persistent vomiting and diarrhoea that prevent you from keeping fluids down can also lead to dehydration, which becomes serious quickly. Beyond these, some people also notice unexpected changes such as hair loss while taking Wegovy, which is worth understanding before you start treatment. The full list of symptoms warranting urgent review is set out on the Wegovy side effects overview, worth bookmarking before you start treatment rather than searching for it in discomfort later.
If you are unsure whether your symptoms cross that line, contact your prescriber or call NHS 111. For suspected side effects, including ones that feel minor but persistent, the right channel is the MHRA Yellow Card scheme, reporting there helps build the evidence base for everyone on these medicines.
Knowing which side effects are expected, which ease off, and which ones require action is part of what a proper clinical consultation covers, not an afterthought. Our prescribers at nume go through this as a routine part of every assessment, so you know what you're likely to experience and what to watch for, including effects such as feeling more tired than usual on Wegovy, which catches some people off guard. If you're considering Wegovy and want to understand whether it's the right fit for you, our free consultation is the place to start that conversation. There's no pressure, and the clinical team are straightforward about both the benefits and the trade-offs.
Wegovy is one of two injectable weight-loss treatments available through nume, if you'd like to compare how semaglutide and tirzepatide differ in their side-effect profiles and results, the weight-loss treatment overview sets that out clearly.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.